您的购物车当前为空
EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1].
EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1].

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,710 | 5日内发货 | |
| 5 mg | ¥ 2,890 | 5日内发货 | |
| 25 mg | ¥ 9,160 | 6-8周 | |
| 50 mg | ¥ 11,900 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
| 产品描述 | EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1]. |
| 体外活性 | EMI56 inhibits EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S. EMI56 can be used in the research of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC)[1].EMI56 (10, 15, 20 μM; 2 h of treatment) strongly inhibits total EGFR levels, activation and downstream signaling in PC9 EGFR ex19del/T790M/C797S cells[1]. |
| 分子量 | 348.4 |
| 分子式 | C21H20N2O3 |
| CAS No. | 2414374-41-5 |
| Smiles | CCN(CC)c1cc2oc(=O)c(cc2cc1C)-c1nc2ccccc2o1 |
| 密度 | 1.259 g/cm3 (Predicted) |
| 存储 | ||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (143.51 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多